SBI, Airtel, Adani Enterprises, TCS and other top stocks to watch out for on August 4

Aug 4, 2021

By: Rounak Jain

Bharti Airtel

The Sunil Mittal-led telco reported a net profit of ₹284 crore in the June quarter versus ₹759 crore three months ago. This is Airtel’s second subsequent profitable quarter in several years. In June last year, it had posted a loss of ₹15,933 crore.

Credit: BCCL

Bharti Airtel

Revenue increased to ₹26,853 crore, up 15 percent in the last 3 months. Avg Revenue Per User edged up to ₹146 from ₹145.

Credit: Bharti-Airtel

Adani Enterprises

Bounced back in the black with a net profit of ₹266 crore in the June quarter as against a loss of ₹66 crore a year ago. Revenue more than doubled to ₹12,579 crore as against ₹5,265 crore, year-on-year.

Credit: Adani-Enterprises

Tata Consultancy Services

Bagged a supply chain modernisation contract from the US-based multinational food products company, Rich Products.

Credit: Tata-Consultancy-Services

Earnings today

SBI, Titan Company, HPCL, Adani Total Gas, Adani Green Energy, Godrej Consumer Products, Tata Communications and more.

Credit: Pixabay

Earnings today

Apollo Tyres, PNB Housing Finance, Borosil Renewables, Sumitomo Chemical India, Tata Steel BSL, Thomas Cook (India), among others.

Credit: Pixabay

IPO opening today

Two new IPOs - Windlas Biotech, and Exxaro Tiles, open today.

Credit: Flickr

Tata Steel

S&P has upgraded Tata Steel’s long-term debt rating saying the debt level and finance cost may decline materially over the next two years.

Credit: Tata-Steel

Tata Consumer

Both tea exports and the coffee chain Starbucks recovered but not strongly enough until the second half of June, the management reportedly said.

Credit: Tata-Consumer

Tata Consumer

Profit fell 42 percent in the June quarter to ₹200 crore. Revenue surged 11 percent to ₹3,008 crore in the same period.

Credit: Tata-Consumer

Dr. Reddy's Laboratories

Relaunched Naproxen Sodium tablets – a pain reliever – in the US after receiving approval from the US Food and Drug Administration.

Credit: Dr-Reddys-Laboratories

Canara Bank

To raise up to ₹2,500 crore through sale of shares and rights to institutional investors before March 2022.

Credit: BCCL

Moderna's vaccine offers better protection against COVID-19 hospitalization than Pfizer or J&J, new CDC study finds